Does race impact outcomes after parathyroidectomy for secondary and tertiary hyperparathyroidism? - 17/10/23
, Alexander M. Fagenson, Sunil S. Karhadkar, Lindsay E. Kuo Abstract |
Background |
Racial disparities in care exist for diseases with heterogeneous treatment guidelines. The impact of these disparities on outcomes after parathyroidectomy for secondary(2HPT) and tertiary hyperparathyroidism(3HPT) was explored.
Methods |
The 2015–2019 NSQIP datasets were used. Patients who underwent parathyroidectomy for 2HPT and 3HPT were identified and analyzed separately. Patients were stratified by race (white vs. non-white); demographics, comorbidities, and outcomes were compared. Studied outcomes included 30-day morbidity, mortality, unplanned reoperation, readmission, and postoperative length of stay(LOS).
Results |
There were 1,150 patients with 2HPT and 262 with 3HPT. For 2HPT, 65.5% were non-white; morbidity, reoperation, and prolonged LOS(>3days) occurred disproportionately more often in non-white patients. Non-white race was independently associated with morbidity; higher ASA class and alkaline phosphatase levels were associated with prolonged LOS. For 3HPT, 53.1% were non-white; a prolonged LOS(>1day) occurred disproportionately more often in non-white patients. Higher alkaline phosphatase levels were independently associated with prolonged LOS.
Conclusion |
Race and markers of advanced disease negatively impact outcomes after parathyroidectomy for 2HPT and 3HPT. Attention to racial disparities and earlier referral may positively impact outcomes.
Il testo completo di questo articolo è disponibile in PDF.Graphical abstract |
Highlights |
• | Most patients with secondary and tertiary hyperparathyroidism are non-white. |
• | Non-white patients disproportionately experience morbidity, prolonged length of stay. |
• | Increased likelihood of morbidity for non-white patients with secondary hyperparathyroidism. |
• | Higher alkaline phosphatase levels are associated with prolonged length of stay. |
Keywords : Secondary hyperparathyroidism, Tertiary hyperparathyroidism, Race
Mappa
Vol 226 - N° 5
P. 652-659 - novembre 2023 Ritorno al numero
Articolo precedente
- Mastectomy margins for ductal carcinoma-in-situ (DCIS): 18 Years of follow-up
- Ayat ElSherif, Mary Freyvogel Ramirez, Edwina C. Moore, Jill R. Dietz, Chao Tu, Stephanie A. Valente
- How surgeons use risk calculators and non-clinical factors for informed consent and shared decision making: A qualitative study
- Jasmine Panton, Brendin R. Beaulieu-Jones, Jayson S. Marwaha, Alison P. Woods, Drashko Nakikj, Nils Gehlenborg, Gabriel A. Brat
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?